Furthermore, BRCA1 deficiency accelerated tumor growth along with GOT2 upregulation by its transcriptional activation (or derepression), which indicates that mCAT could act as a metabolic malignancy driver in the absence of BRCA1 or ZBRK1 in breast cancer. The gene discussed is BRCA1; the disease is breast carcinoma.